View in EDS HTML Full Text PDF Full Text

Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells.

Saved in:

Bibliographic Details
Title:	Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells.
Authors:	Golumba‐Nagy, Viktoria¹ (AUTHOR), Yan, Shuaifeng¹ (AUTHOR), Steinbach‐Knödgen, Eva¹ (AUTHOR), Thiele, Jan¹ (AUTHOR), Esser, Ruth L.¹ (AUTHOR), Haak, Thomas H.^1,2 (AUTHOR), Nikiforov, Anastasia^1,3 (AUTHOR), Meyer, Anja¹ (AUTHOR), Seeger‐Nukpezah, Tamina^1,3 (AUTHOR), Kofler, David M.^1,3 (AUTHOR) david.kofler@uk‐koeln.de
Source:	Physiological Reports. Oct2023, Vol. 11 Issue 19, p1-8. 8p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!